Wistar Wire: Melanoma

Ben Leach
Ashani Weeraratna, Ph.D.
Ashani Weeraratna, Ph.D.
In a Medscape article covering research being presented at the American Society of Clinical Oncology meeting next month, Wistar's Ashani Weeraratna, Ph.D., commented on a new study comparing two treatments for melanoma.
Cancer, Melanoma
Ben Leach
Ashani Weeraratna, Ph.D.
Ashani Weeraratna, Ph.D.
In a landmark study, Wistar’s Ashani Weeraratna and her colleagues showed how some therapies that work in younger patients might not provide the same benefits for older patients with the same disease.
Cancer, Melanoma
Darien Sutton
Jeremy Moore during speed science
Jeremy Moore during speed science
Ambassadors came out for speed science—yes that exists! Opportunity to meet scientists and converse on work revolving around telomerase function, ovarian cancer and melanoma.
Cancer, Events, Melanoma
Ben Leach
Dr. Meenhard Herlyn
Dr. Meenhard Herlyn
New research from the lab of Dr. Meenhard Herlyn shows that a combination of drugs might be able to halt mutated melanoma cells from finding alternative pathways and new ways to grow and spread after being treated with targeted therapies.
Cancer, Genes, Melanoma